Dr. Yungan Tao is radiation oncologist of head and neck / dermatology / endocrinology in Department of Radiation oncology of Institut Gustave-Roussy.
Besides, Dr. Tao is President-Elect and member of the board of directors and scientific committee in French head and neck oncology radiotherapy group (GORTEC).
Board member representing French intergroupe/ GORTEC in Head and Neck Cancer International Group (HNCIG).
Expert Panelist for nasopharyngeal cancer project in the International Atomic Energy Agency (IAEA).
Head and neck cancer Track Co-Chair (representing Europe) in Scientific Committee of ESMO (European Society for Medical Oncology) Asia Congress 2025
ESMO Chair for ICHNO 2026-2028 (International Congress on Innovative Approaches in Head and Neck Oncology).
Dr. Tao is principle investigator or co-PI of several phase II/III studies, such as GORTEC 2007-01, PembroRad, DEBIO-1143-201, REACH, Nivo-Postop, utilising new radiotherapy technology, association of targeted therapy or immunotherapy with (chemo) radiotherapy, etc. Implicated as main role in several large-scale phase 3 trials such as KeyNote-412, KeyNote-689 and Trilynx.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none